Post-COVID depression among a sample of Egyptian patients and its associated factors

• Published in: The Egyptian Journal of Bronchology 2021-12, Vol.15 (1), p.1-7, Article 44
• Main Authors: Ezzelregal, Hieba Gamal, Hassan, Azza Mohammed, Mohamed, Rehab Serag, Ahmed, Noha Othman
• Format: Article
• Language: English
• Subjects: Age groups; Chronic obstructive pulmonary disease; Coronaviruses; Councils; COVID-19; Cross-sectional studies; Depression; Diabetes; Dyspnea; Education; Females; Fever; Gender; Hypertension; Illnesses; Kidney diseases; Medical research; Medicine; Medicine & Public Health; Mental depression; Oxygen saturation; Psychiatry; Psychological dyspnoea; Pulmonary disease; Regression analysis; Respiratory diseases; Secondary education; Steroids; Walking
• ISSN: 1687-8426; 2314-8551
• DOI: 10.1186/s43168-021-00086-7

Background Depression is classified as a mood disorder. It may be described as feelings of sadness, loss, or anger that interfere with a person’s everyday activities. Nowadays, we are in COVID-19 pandemic. From practice after COVID-19 illness resolves, some of the recovering patients return back smoothly to their pre-illness life. Others experience different mood changes. Anxiety and depression are the most common. Those patients with improving general health, radiology, and oxygenation have different somatic complaints such as sensation of dyspnoea. Psychological support and psychiatric evaluation can help them to overcome this situation and get rid of dyspnoea sensation. This work aimed to evaluate the relation between COVID-19 survivors and depression and to how extent this could affect functional status of the study participants. Results This work recruited 102 adult patients as a sample of Egyptians who were positive PCR for SARS-COV2, turned negative and free of symptoms for 1 month or more which include physicians, nurses, employees, and literate health care workers of Ain Shams University hospitals attending chest outpatient clinic for follow-up. The majority were 47.1% in age group (35–55 years), sixty two (60.8%) participants were females, 74.5% had high education, and 24.5% were smokers. The most frequent symptom reported by study participants as the most annoying COVID-19 symptom was fever (32.4%). Beck depression inventory score showed that 59 (57.8%) participants had no depression, 24 (23.5%) had mild depression, 16 (15.7%) had moderate depression, and only 3 (2.9%) participants had severe depression. Logistic regression analysis was done to measure effect of steroid use and grade of dyspnoea on development of moderate or severe post-COVID depression and showed that higher grades of dyspnoea were associated with higher probability of development of moderate or severe post-COVID depression ( p value < 0.05). Conclusion As predicted, COVID-19 survivors presented a high prevalence of psychiatric sequelae. Age, sex, and education level were important association factors. Higher educational level was associated with higher score of depression due to increased awareness of the current pandemic issue. Steroids’ use was proposed as a cause of depression since the majority of moderate or severe depression group were on steroids. Higher grades of dyspnoea were associated with higher probability of development of moderate or severe post-COVID depression